| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2020 | Apr 13, 2020 | Avalo Therapeutics, Inc. | Chair | Sell | 22.5 | -20,901 | -7.96% | ✗ | $53.7K |
| Aug 27, 2019 | Aug 29, 2019 | Avalo Therapeutics, Inc. | Chair | Buy | 83.8 | +6,734 | 2.63% | ✗ | $20.1K |
| May 14, 2019 | May 16, 2019 | Avalo Therapeutics, Inc. | Chair | Buy | 91.3 | +6,000 | 100.00% | ✗ | $30.3K |
| Aug 20, 2014 | Aug 22, 2014 | Cellectar Biosciences, Inc. | CEO | Buy | 91.3 | +13,300 | 100.00% | ✗ | $49.9K |